Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01404
Species: Homo sapiens
Position : chr11:69419632-69420080
Year: 2022
Title: The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: osteosarcoma
PMID:  35676472
MONDO: MONDO:0005087
Tissue: Bone
Tissue Ontology ID: UBERON:0001474
Cell Source: OS-LM1
CVCL ID:
Cell Type: osteosarcoma cell
Cell Ontology ID: CL:0000062
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPRi, ChIP-RT-qPCR, RT-RT-qPCR, EMSA
About Target Gene
Target gene : CCND1
About TF
TF name : PAX8
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
PAX8 ID netpath 38
PAX8 Pathways in cancer kegg 321
PAX8 Thyroid cancer kegg 25
PAX8 Hs_Thyroid_Stimulating_Hormone_(TSH)_signaling_pathway_WP2032_89823 wikipathways 28
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_01323 chr11:69419632-69420080 Kidney kidney cancer cell renal cell carcinoma
Expression of Target Genes for the Enhancer